| Tender Number | 4375201 |
|---|---|
| Buyer | |
| Location | Multi city, Multi State |
| Awarded Value | ₹ 738,850 |
| Selected Bidder |
Inj Dexmedetomide 100mcg per ml 50ml,Ketamine Hcl 50mg per ml 2ml inj,Propofol 1percent or 10mg per ml 20ml Inj,Bupivacaine HCL 5mg per ml 20 ml Inj,Bupivacaine HCL 5mg per ml heavy 4ml Inj,Lignocaine HCL 2 percent with Adrenaline 1 isto 80000 30ml Inj,Ligacaine 100mg and Ethanol 28 percent spray container 500ml,Lignocaine HCL jelly 2 percent,Ibuprofen Syrup 100mg per 5ml bott of 50ml,Pethedine 50mg 1ml Inj,Tramadol Hcl 50mg cap per tab,Cyproheptadine 4mg Tab,Dexamethasone Sodium Phosphate 4mg per ml 2ml Inj,Methylprednisolone 16mg Tab,Promethazine Hcl 2point5 percent 25mg per ml 2ml Inj,Levetiracetam 100mg per ml Inj vial of 5ml,Levetiracetam 100mg per ml syr soln liquid bott of 100ml,Clobazam 5mg Tab,Clonapezam 2mg Tab,Diazepam 10mg 2ml Inj,Phenobarbitone Sodium 200mg 1ml Inj,Sodium Valproate 100mg per ml Inj,Sodium Valproate 200mg tab,Baclofen 10mg Tab,Budesonide 200mcg inhaler,Budesonide 200mcg plus Formeterol 6mcg autohaler,Budesunide 1mg Respules,Chlorzoxazone 500mg plus Diclofenac Sodium 50mg plus Para
| AOC | Mon 25th May, 2026 |
|---|
| Document Name | Action |
|---|---|
| Tender Notice | Sign Up to Download |
Company Study
We evaluate your eligibility, strengths, certifications, and past performance to align with buyer requirements.
Competitor Analysis
We study likely bidders, past AOCs, pricing bands, and technical patterns to position your bid smartly.
Submission & JV Execution
We prepare compliant documents, set up JV agreements, and handle portal uploading end-to-end.
| # | Name | Value | Position | Status |
|---|---|---|---|---|
| 1 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 2 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 3 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 4 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 5 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 6 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 7 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 8 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 9 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 10 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 11 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 12 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 13 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 14 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 15 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 16 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 17 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 18 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 19 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 20 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 21 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 22 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 23 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 24 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |
| 25 | APEX DRUG HOUSE | 738850.47 | L1 | Qualified |
| 26 | SHRI RUDRANSH MEDICINE AGENCY | 741000.90 | L2 | Qualified |
| 27 | KANDA ENTERPRISES | 1151033.10 | L3 | Qualified |